BI 705564 in Patients With Systemic Lupus Erythematosus (SLE)

Condition:   Lupus Erythematosus, Systemic Interventions:   Drug: BI 705564;   Drug: Placebo Sponsor:   Boehringer Ingelheim Not yet recruiting

Source: ClinicalTrials.gov - December 11, 2018 Category: Research Source Type: clinical trials